Meinian Onehealth Healthcare Holdings Co., Ltd. (SHE:002044)
China
· Delayed Price · Currency is CNY 5.65
+0.01 (0.18%)
Apr 1, 2025, 2:45 PM CST
SHE:002044 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 10,727 | 10,870 | 8,602 | 9,200 | 7,824 | 8,485 | Upgrade
|
| Other Revenue | 23.21 | 23.21 | 14.18 | 15.96 | 24.07 | 40.43 | Upgrade
|
| Revenue | 10,750 | 10,894 | 8,616 | 9,216 | 7,848 | 8,525 | Upgrade
|
| Revenue Growth (YoY) | 6.27% | 26.44% | -6.51% | 17.43% | -7.94% | 0.79% | Upgrade
|
| Cost of Revenue | 6,171 | 6,232 | 5,649 | 5,580 | 4,934 | 4,790 | Upgrade
|
| Gross Profit | 4,579 | 4,661 | 2,967 | 3,636 | 2,914 | 3,735 | Upgrade
|
| Selling, General & Admin | 3,484 | 3,395 | 2,863 | 2,819 | 2,474 | 2,634 | Upgrade
|
| Research & Development | 58.53 | 62.65 | 56.35 | 60.22 | 45.91 | 46.65 | Upgrade
|
| Other Operating Expenses | -0.16 | 3.73 | 2.6 | 1.76 | 1.12 | 11.82 | Upgrade
|
| Operating Expenses | 3,608 | 3,446 | 3,074 | 2,962 | 2,675 | 2,778 | Upgrade
|
| Operating Income | 970.83 | 1,216 | -106.83 | 674.33 | 239.16 | 956.55 | Upgrade
|
| Interest Expense | -541.27 | -303.68 | -291.43 | -353.66 | -373.79 | -410.97 | Upgrade
|
| Interest & Investment Income | 21.28 | 21.63 | 14.06 | 88.04 | 1,267 | 152.96 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.02 | -0.02 | -0.33 | 2.17 | 73.58 | -11.16 | Upgrade
|
| Other Non Operating Income (Expenses) | 204.19 | -16.48 | -24.98 | -32.81 | -86.88 | -66.78 | Upgrade
|
| EBT Excluding Unusual Items | 655.01 | 917.01 | -409.52 | 378.07 | 1,119 | 620.6 | Upgrade
|
| Impairment of Goodwill | -41.86 | -41.86 | - | - | -327.3 | -1,035 | Upgrade
|
| Gain (Loss) on Sale of Investments | 7.33 | 1.78 | 5.84 | -0.57 | -4.43 | -47.52 | Upgrade
|
| Gain (Loss) on Sale of Assets | -10.51 | -6.89 | -8.16 | -6.17 | -4.92 | -6.14 | Upgrade
|
| Asset Writedown | -26.08 | -26.96 | -66.84 | -28.27 | -36.77 | -30.09 | Upgrade
|
| Legal Settlements | - | - | - | -7.92 | -5.6 | -5.79 | Upgrade
|
| Other Unusual Items | 4.96 | 4.96 | 27.96 | 29.61 | 36.51 | 18.01 | Upgrade
|
| Pretax Income | 588.86 | 848.06 | -450.72 | 364.75 | 776.32 | -485.75 | Upgrade
|
| Income Tax Expense | 145.64 | 179.23 | 50.86 | 205.57 | 140.56 | 227.99 | Upgrade
|
| Earnings From Continuing Operations | 443.22 | 668.82 | -501.58 | 159.19 | 635.76 | -713.74 | Upgrade
|
| Minority Interest in Earnings | -136.09 | -163.2 | -57.44 | -97.61 | -84.74 | -152.74 | Upgrade
|
| Net Income | 307.13 | 505.62 | -559.02 | 61.58 | 551.02 | -866.47 | Upgrade
|
| Net Income to Common | 307.13 | 505.62 | -559.02 | 61.58 | 551.02 | -866.47 | Upgrade
|
| Net Income Growth | 486.38% | - | - | -88.83% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 2,948 | 3,889 | 3,993 | 3,079 | 3,936 | 3,767 | Upgrade
|
| Shares Outstanding (Diluted) | 2,948 | 3,889 | 3,993 | 3,079 | 3,936 | 3,767 | Upgrade
|
| Shares Change (YoY) | -23.83% | -2.60% | 29.69% | -21.77% | 4.48% | 0.50% | Upgrade
|
| EPS (Basic) | 0.10 | 0.13 | -0.14 | 0.02 | 0.14 | -0.23 | Upgrade
|
| EPS (Diluted) | 0.10 | 0.13 | -0.14 | 0.02 | 0.14 | -0.23 | Upgrade
|
| EPS Growth | 669.90% | - | - | -85.71% | - | - | Upgrade
|
| Free Cash Flow | 1,113 | 1,616 | 1,128 | 1,624 | 656.36 | 830.37 | Upgrade
|
| Free Cash Flow Per Share | 0.38 | 0.41 | 0.28 | 0.53 | 0.17 | 0.22 | Upgrade
|
| Dividend Per Share | 0.019 | 0.019 | - | - | - | - | Upgrade
|
| Gross Margin | 42.59% | 42.79% | 34.44% | 39.46% | 37.13% | 43.81% | Upgrade
|
| Operating Margin | 9.03% | 11.16% | -1.24% | 7.32% | 3.05% | 11.22% | Upgrade
|
| Profit Margin | 2.86% | 4.64% | -6.49% | 0.67% | 7.02% | -10.16% | Upgrade
|
| Free Cash Flow Margin | 10.35% | 14.83% | 13.09% | 17.62% | 8.36% | 9.74% | Upgrade
|
| EBITDA | 1,385 | 1,643 | 337.89 | 1,094 | 646.8 | 1,357 | Upgrade
|
| EBITDA Margin | 12.89% | 15.08% | 3.92% | 11.87% | 8.24% | 15.91% | Upgrade
|
| D&A For EBITDA | 414.6 | 427.51 | 444.73 | 419.94 | 407.64 | 400.11 | Upgrade
|
| EBIT | 970.83 | 1,216 | -106.83 | 674.33 | 239.16 | 956.55 | Upgrade
|
| EBIT Margin | 9.03% | 11.16% | -1.24% | 7.32% | 3.05% | 11.22% | Upgrade
|
| Effective Tax Rate | 24.73% | 21.13% | - | 56.36% | 18.11% | - | Upgrade
|
| Revenue as Reported | 10,750 | 10,894 | 8,616 | 9,216 | 7,848 | 8,525 | Upgrade
|
| Advertising Expenses | - | 72.53 | 67.81 | 94.96 | 94.03 | 99.28 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.